Zhijiang Biotechnology (688317.SH): The relevant biotechnology bills in the USA have not involved the company.

Zhejiang Biotechnology (688317.SH) stated on the interactive platform on September 18th that the relevant biotechnology legislation in the United States has not involved our company and has no direct impact. The company's main business is running normally and steadily. The company will closely monitor this matter.

Gelonghui FinanceSep 18 04:11 ET

Zhijiang Biology (688317.SH): has obtained the monkeypox product EU CE and UK MHRA certification.

On September 2, GeLongHui reported that ZhiJiang Biology (688317.SH) stated on the interactive platform that the company has obtained EU CE and United Kingdom MHRA certification for smallpox products, allowing sales in EU countries, the United Kingdom, and countries with relevant certifications. The company will continue to closely monitor the development of smallpox-related epidemics in overseas markets.

Gelonghui FinanceSep 2 03:32 ET

Zhijiang Biotech: 2024 Semi-Annual Report

SZSIAug 28 12:00 ET · Announcements

Zhijiang Biotech: 2024 Semi-Annual Report Summary

SZSIAug 28 12:00 ET · Announcements

Zhijiang Biology (688317.SH) released its semi-annual performance report, with a net income of 26.005 million yuan, a year-on-year decrease of 17.76%.

Zhi Jiang Biotech (688317.SH) has released its semi-annual report for 2024, reporting revenue of 9...

Zhitong FinanceAug 28 05:47 ET

Zhijiang Biology (688317.SH): The net income for the first half of the year was 26.005 million yuan, a decrease of 17.76% compared to the same period last year.

Zhejiang Biotechnology (688317.SH) released its semi-annual report on August 28th. During the reporting period, the company achieved revenue of 94.5959 million yuan, a year-on-year decrease of 35.61%. The net income attributable to shareholders of the listed company was 26.005 million yuan, a year-on-year decrease of 17.76%. The net income attributable to the listed company after deducting non-recurring gains and losses was 23.5408 million yuan, a year-on-year decrease of 1.25%. A cash dividend of 1.1 yuan per 10 shares was distributed to all shareholders.

Gelonghui FinanceAug 28 04:42 ET